gip glp 1 agonist tirzepatide Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Response in Type 2 Diabetes and Atherosclerosis Bumps and humps in the

We are in a new era for obesity pharmacotherapy where combinations of entero-pancreatic hormones approach the WL achieved with bariatric surgery

Where does the rise of GLP-1s leave the body positivity movement

Diabetes was the eighth leading cause of death in 2021 and drastically affects the quality of life for those who have this disease

10.1038/s42255-021-00344-4 Nat

The point is not that you should be able to read all the side-effects, but rather impress upon you that all medications have potential side effects, and many have lots of them

Moreover, a recent SURPASS-3 MRI substudy has shown that tirzepatide may be more effective in reducing liver fat than insulin degludec [93]